In a compelling call to action, James Roguski emphasizes the urgency for individuals worldwide to voice their opposition to the World Health Organization’s proposed “Pandemic Agreement,” a decision that is expected to be announced soon. By November 11, 2024, the Intergovernmental Negotiating Body (INB) will determine whether a special session of the World Health Assembly will take place on December 18-20, 2024. Should this occur, the agreement could become legally binding within days, placing signatory nations under its provisions for three years. Roguski underscores that it is the responsibility of the global populace to express dissent against what he sees as an expedited and undemocratic process to ratify a framework perceived to benefit a select few.
Roguski critiques the intentions behind the proposed agreement, suggesting that it centralizes power among unelected bureaucrats whose motivations are primarily profit-driven rather than health-oriented. He argues that this initiative is not genuinely aimed at preventing future pandemics but is rather designed to entrench the interests of the pharmaceutical industry. Pointing to the failures of regulatory agencies that have allegedly been co-opted by these interests, he asserts that the “Pandemic Treaty” serves as a mechanism for wealth accumulation among those already in power, ignoring the public’s needs and concerns.
The article further articulates concerns regarding the financial implications of the agreement, emphasizing that the funds allocated towards developing pandemic responses serve to enrich pharmaceutical companies rather than enhance public health. Roguski suggests that rather than addressing the root causes of health crises or improving the overall health infrastructure, this agreement channels vast resources into a system that contributes to the profitability of the pharmaceutical sector under the guise of promoting “sustainable financing” and equitable access to necessary health products.
Roguski’s critical stance is bolstered by his assertion that the existing health paradigms are flawed and that iatrogenesis—adverse effects caused by medical treatment—is a leading cause of death globally. He views the “Pandemic Agreement” as a corrupt enterprise that prioritizes profit over public health needs, particularly when the pharmaceutical industry is already witnessing significant gains amid ongoing health crises. The proposal, according to Roguski, fails to address genuine health improvement strategies and instead appears focused on expanding the Pharmaceutical Hospital Emergency Industrial Complex (PHEIC).
In response to these developments, Roguski encourages individuals to take immediate action before the November deadline, urging them to make their voices heard, participate in discussions, and engage with decision-making processes surrounding the agreement. He emphasizes the importance of public mobilization in countering what he perceives as a top-down approach to pandemic preparedness and response that lacks transparency and accountability.
Ultimately, Roguski’s article serves as a rallying cry for collective action against what he and many others consider an alarming attempt by global elites to consolidate power through the proposed “Pandemic Agreement.” By advocating for heightened public awareness and participation, he reinforces the belief that informed and engaged citizens are essential in holding governmental bodies accountable and ensuring that health policies reflect the needs and wishes of the broader community rather than the interests of a select few.
